Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)

Objective: Heterozygous familial hypercholesterolaemia (FH) is a common autosomal dominant disorder. The vast majority of affected individuals remain undiagnosed, resulting in lost opportunities for preventing premature heart disease. Better use of routine primary care data offers an opportunity to...

Full description

Bibliographic Details
Main Authors: Weng, Stephen F., Kai, Joe, Neil, H. Andrew, Humphries, Steve E., Qureshi, Nadeem
Format: Article
Published: Elsevier 2015
Subjects:
Online Access:https://eprints.nottingham.ac.uk/50104/
_version_ 1848798155054776320
author Weng, Stephen F.
Kai, Joe
Neil, H. Andrew
Humphries, Steve E.
Qureshi, Nadeem
author_facet Weng, Stephen F.
Kai, Joe
Neil, H. Andrew
Humphries, Steve E.
Qureshi, Nadeem
author_sort Weng, Stephen F.
building Nottingham Research Data Repository
collection Online Access
description Objective: Heterozygous familial hypercholesterolaemia (FH) is a common autosomal dominant disorder. The vast majority of affected individuals remain undiagnosed, resulting in lost opportunities for preventing premature heart disease. Better use of routine primary care data offers an opportunity to enhance detection. We sought to develop a new predictive algorithm for improving identification of individuals in primary care who could be prioritised for further clinical assessment using established diagnostic criteria. Methods: Data were analysed for 2,975,281 patients with total or LDL-cholesterol measurement from 1 Jan 1999 to 31 August 2013 using the Clinical Practice Research Datalink (CPRD). Included in this cohort study were 5050 documented cases of FH. Stepwise logistic regression was used to derive optimal multivariate prediction models. Model performance was assessed by its discriminatory accuracy (area under receiver operating curve [AUC]). Results: The FH prediction model (FAMCAT), consisting of nine diagnostic variables, showed high discrimination (AUC 0.860, 95% CI 0.848–0.871) for distinguishing cases from non-cases. Sensitivity analysis demonstrated no significant drop in discrimination (AUC 0.858, 95% CI 0.845–0.869) after excluding secondary causes of hypercholesterolaemia. Removing family history variables reduced discrimination (AUC 0.820, 95% CI 0.807–0.834), while incorporating more comprehensive family history recording of myocardial infraction significantly improved discrimination (AUC 0.894, 95% CI 0.884–0.904). Conclusion: This approach offers the opportunity to enhance detection of FH in primary care by identifying individuals with greatest probability of having the condition. Such cases can be prioritised for further clinical assessment, appropriate referral and treatment to prevent premature heart disease.
first_indexed 2025-11-14T20:15:16Z
format Article
id nottingham-50104
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:15:16Z
publishDate 2015
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling nottingham-501042020-05-04T17:01:55Z https://eprints.nottingham.ac.uk/50104/ Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT) Weng, Stephen F. Kai, Joe Neil, H. Andrew Humphries, Steve E. Qureshi, Nadeem Objective: Heterozygous familial hypercholesterolaemia (FH) is a common autosomal dominant disorder. The vast majority of affected individuals remain undiagnosed, resulting in lost opportunities for preventing premature heart disease. Better use of routine primary care data offers an opportunity to enhance detection. We sought to develop a new predictive algorithm for improving identification of individuals in primary care who could be prioritised for further clinical assessment using established diagnostic criteria. Methods: Data were analysed for 2,975,281 patients with total or LDL-cholesterol measurement from 1 Jan 1999 to 31 August 2013 using the Clinical Practice Research Datalink (CPRD). Included in this cohort study were 5050 documented cases of FH. Stepwise logistic regression was used to derive optimal multivariate prediction models. Model performance was assessed by its discriminatory accuracy (area under receiver operating curve [AUC]). Results: The FH prediction model (FAMCAT), consisting of nine diagnostic variables, showed high discrimination (AUC 0.860, 95% CI 0.848–0.871) for distinguishing cases from non-cases. Sensitivity analysis demonstrated no significant drop in discrimination (AUC 0.858, 95% CI 0.845–0.869) after excluding secondary causes of hypercholesterolaemia. Removing family history variables reduced discrimination (AUC 0.820, 95% CI 0.807–0.834), while incorporating more comprehensive family history recording of myocardial infraction significantly improved discrimination (AUC 0.894, 95% CI 0.884–0.904). Conclusion: This approach offers the opportunity to enhance detection of FH in primary care by identifying individuals with greatest probability of having the condition. Such cases can be prioritised for further clinical assessment, appropriate referral and treatment to prevent premature heart disease. Elsevier 2015-02-28 Article PeerReviewed Weng, Stephen F., Kai, Joe, Neil, H. Andrew, Humphries, Steve E. and Qureshi, Nadeem (2015) Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT). Atherosclerosis, 238 (2). pp. 336-343. ISSN 0021-9150 Identification; Familial hypercholesterolaemia; Primary care; Derivation and validation; Familial Hypercholesterolaemia Case Ascertainment Tool; FAMCAT https://www.sciencedirect.com/science/article/pii/S0021915014016566 doi:10.1016/j.atherosclerosis.2014.12.034 doi:10.1016/j.atherosclerosis.2014.12.034
spellingShingle Identification; Familial hypercholesterolaemia; Primary care; Derivation and validation; Familial Hypercholesterolaemia Case Ascertainment Tool; FAMCAT
Weng, Stephen F.
Kai, Joe
Neil, H. Andrew
Humphries, Steve E.
Qureshi, Nadeem
Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
title Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
title_full Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
title_fullStr Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
title_full_unstemmed Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
title_short Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
title_sort improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (famcat)
topic Identification; Familial hypercholesterolaemia; Primary care; Derivation and validation; Familial Hypercholesterolaemia Case Ascertainment Tool; FAMCAT
url https://eprints.nottingham.ac.uk/50104/
https://eprints.nottingham.ac.uk/50104/
https://eprints.nottingham.ac.uk/50104/